• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Active Biotech AB - Product Image

Active Biotech AB

  • ID: 644077
  • February 2015
  • 56 Pages
  • Wright Investors Service

A textual analysis of the financial results for Active Biotech AB compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business description of the company, including contact information, senior officers and Wright Quality Rating analyses is also provided.

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio tables (Accounting, Asset Utilization, Employee Efficiency, Fixed Charges Coverage, Leverage Analysis, Liquidity Analysis, Per-share Data and Profitability Analysis) and proprietary Wright Quality Rating analyses tables. The Wright Quality Rating, a measure of corporate risk, examines the liquidity of the stock, financial strength, profitability and corporate growth characteristics of Active Biotech AB. There is a textual review of the financial results of Active Biotech AB versus Allenex AB, Bioinvent International AB and Karo Bio AB. The comparative analysis of these companies compares Sales (sales, sales growth and sales per employee), Company Valuations (Price/Earnings, Price/Book, Price/Sales and 52-Week Price Change) and Financial Position (Long-term Debt/Equity). Also included for Active Biotech AB are the Company Description, Recent Stock Performance, Profitability Analysis, Dividend Analysis, and Key Data Items (Ticker, Major Industry, Sub-Industry, Fiscal Year End Month, Employees, Share Type, Market Capitalization, Total Shares Outstanding and Number of Closely Held Shares.) Additional research for Active Biotech AB includes tables with up to 10-years of history of computed ratios, sales, earnings, and security prices.

Note: Product cover images may vary from those shown

Company Fundamentals
- Company Profile
- Comparative Business Analysis
- Summary Analysis per Share
- Sales Analysis
- Price Analysis
- Earnings and Dividends Analysis

Financial Statement Analyses
- Balance Sheet - Common Size
- Balance Sheet - Year-Year Percent Change
- Balance Sheet - Five-Year Averages
- Income Statement - Common Size
- Income Statement - Year-Year Percent Change
- Income Statement - Five-Year Averages
- Sources of Capital

Financial Ratio Analyses
- Accounting Ratios
- Asset Utilization
- Employee Efficiency
- Fixed Charges Coverage
- Leverage Analysis
- Liquidity Analysis
- Per-Share Data
- Profitability Analysis

Wright Quality Rating Analyses
- Investment Acceptance
- Financial Strength
- Profitability and Stability
- Corporate Growth

Note: Product cover images may vary from those shown

Cyprotex PLC, Biotie Therapies and Jerini AG

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

  • Topotarget A/S - Product Thumbnail Image

    Topotarget A/S

    • Language: English
    • 56 Pages
    • Published: July 2014
  • Biotie Therapies - Product Thumbnail Image

    Biotie Therapies

    • Language: English
    • 56 Pages
    • Published: March 2015
    FROM
  • Bioinvent International AB - Product Thumbnail Image

    Bioinvent International AB

    • Language: English
    • 56 Pages
    • Published: February 2015
    • Region: Global
    FROM
  • Karo Bio AB - Product Thumbnail Image

    Karo Bio AB

    • Language: English
    • 55 Pages
    • Published: February 2015
    FROM
  • Medivir AB - Product Thumbnail Image

    Medivir AB

    • Language: English
    • 56 Pages
    • Published: February 2015
    FROM
  • Novus Group International Ab - Product Thumbnail Image

    Novus Group International Ab

    • Language: English
    • 54 Pages
    • Published: October 2014
    • Region: Global
  • IDL Biotech AB - Product Thumbnail Image

    IDL Biotech AB

    • Language: English
    • 56 Pages
    • Published: January 2015
  • Allenex AB - Product Thumbnail Image

    Allenex AB

    • Language: English
    • 56 Pages
    • Published: February 2015
    FROM
  • Pharma and Biotech M&A Trends 2009-2014 [old name Merger & Acquisition Terms and Agreements] - Product Thumbnail Image Pharma and Biotech M&A Trends 2009-2014 [old name Merger & Acquisition Terms and Agreements]

    Pharma and Biotech M&A Trends 2009-2014 [old name Merger & Acquisition Terms and Agreements]

    • Language: English
    • 1677 Pages
    • Published: July 2014
    • Region: Global
    FROM
  • Active Biotech AB (ACTI) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image
    FROM

Our Clients

Fluidigm Corporation Apple, Inc. CEVA Santé Animale Abbott Laboratories Ltd. Merck Group Allergan Inc. Pfizer, Inc.